欢迎访问ProbeChem中文网站,英文网站请访问www.probechem.com

首页-抗体药物偶连体和PROTACs-PROTAC-CFT-2718
CFT-2718

Chemical Structure : CFT-2718

CAS No.:

CFT-2718 (CFT2718)

货号: PC-72644Not For Human Use, Lab Use Only.

CFT-2718 (CFT2718) is a benzotriazoloazepine-based BRD4 degrader, rapidly and selectively degrade BRD4 in vitro in a CRBN-dependent manner (DC90=10 nM, 293T cells).

规格 价格 库存 数量
25 mg Get quote
50 mg Get quote
100 mg Get quote

大包装,大折扣!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

纯度 & COA & 质检文件 纯度: >98% (HPLC) Select Batch:

    生物&药学活性

    CFT-2718 (CFT2718) is a benzotriazoloazepine-based BRD4 degrader, rapidly and selectively degrade BRD4 in vitro in a CRBN-dependent manner (DC90=10 nM, 293T cells).
    CFT-2718 is more effective than dinaciclib in controlling cell growth and efficiently reduces BRD4 expression in vitro (H69 cell IC50: 0.02 versus 17.38 nM).
    CFT-2718 is more effective than dinaciclib in control of PDX tumor models in vivo.
    CFT-2718 selectively increased the expression of cleaved PARP, an indicator of apoptosis.
    CFT-2718 caused rapid BRD4 degradation and reduced levels of total and pSer2 RPB1 protein.

    物理化学性质&存储条件

    分子量 811.388
    分子式 C45H47ClN10O3
    外观性状 Solid
    CAS No.
    储存条件
    固体粉末
    -20°C 12 个月; 4°C 6 个月
    配置液
    -80°C 6 个月; -20°C 6 个月
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    O=C(C(N(CC1=C2C=CC=C1N[C@H]3CN(CCCCCCN4N=CC(C5=CC=C(N6C(C7(CC7)N=C8C9=CC=C(Cl)C=C9)=NN=C6C)C8=C5)=C4)CC3)C2=O)CC%10)NC%10=O

    参考文献

    1. Sun D, et al. Mol Cancer Ther. 2021 Aug;20(8):1367-1377.

    备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    联系我们 sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    询单

    • *产品名称:
    • *姓名:
    • *邮箱:
    • *公司名称:
    • *询单数量:
    • *国籍:
    • 询单信息: